Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Usefulness of Calprotectin for Colon Adenoma Screening

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2012 by Chul Min Park, MD, Konkuk University Medical Center.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Chul Min Park, MD, Konkuk University Medical Center Identifier:
First received: October 30, 2012
Last updated: November 12, 2012
Last verified: November 2012
The fecal calprotectin assay is used widely for inflammatory bowel disease diagnosis and the assessment of the disease activity. Some adenoma patients have elevated fecal calprotectin level, which could mean the role of fecal calprotectin as a screening marker for colon adenoma. We will investigate the usefulness of fecal calprotectin as colon adenoma marker for screening in this study.

Colon Adenoma

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Usefulness of Fecal Calprotectin for Screening Colon Adenoma in Korean Population

Resource links provided by NLM:

Further study details as provided by Chul Min Park, MD, Konkuk University Medical Center:

Primary Outcome Measures:
  • fecal calprotectin level [ Time Frame: 1 day (at the hospital visit) ]

Biospecimen Retention:   Samples Without DNA
stool specimen

Estimated Enrollment: 500
Study Start Date: October 2012
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
patients who visit KUH healthcare center for colonoscopy in Korea over 18 years old adult population

Inclusion Criteria:

  • over 18 years old adult population

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01719198

Korea, Republic of
Konkuk University Medical Center Recruiting
Seoul, Korea, Republic of, 147-729
Contact: Chul Min Park, MD   
Sub-Investigator: Chul Min Park, MD         
Sponsors and Collaborators
Konkuk University Medical Center
Principal Investigator: Yeo-Min Yun, MD, PhD Konkuk University
  More Information

Responsible Party: Chul Min Park, MD, clinical instructor, Konkuk University Medical Center Identifier: NCT01719198     History of Changes
Other Study ID Numbers: KUH1220
Study First Received: October 30, 2012
Last Updated: November 12, 2012

Keywords provided by Chul Min Park, MD, Konkuk University Medical Center:

Additional relevant MeSH terms:
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Neoplasms processed this record on May 25, 2017